Categories: Forex News

JPY unlikely to outlive a CPI surprise-driven USD rally, BofA says


Investing.com — The yen has stood agency in opposition to current greenback power because the dump in markets sparked bids into the safe-haven forex, however ought to U.S. inflation knowledge later this week shock to the upside, this resilience is unlikely to outlive, methods from BofA World Analysis mentioned in a current word.   

“If US CPI surprises to the upside this week, upward strain for USDJPY spot is prone to resume, as a result of pair’s excessive sensitivity to CPI surprises,” the strategists mentioned.

The Japanese yen has remained resilient in opposition to the greenback’s current broad-based rally, supported by its standing as a risk-off hedge amid fairness pullbacks and the already elevated USDJPY spot stage, this might change with the upcoming U.S. Shopper Worth Index, or CPI, report, they added.

BofA’s expects core CPI print, which strips out meals and power, of 0.3% month-over-month, barely above the 0.2% consensus. The CPI is knowledge are slated for launch on Wednesday.

The financial institution’s pattern mannequin reveals a bullish continuation sign for the USDJPY spot uptrend, suggesting additional upside potential for the pair. Nonetheless, a draw back CPI shock and a hawkish speech from the Financial institution of Japan’s deputy governor Ryozo Himino this week are dangers to the bullish name on USD/JPY, the strategists mentioned.

Himino is predicted to ship a speech Tuesday simply weeks earlier than the BoJ assembly on Jan. 23-24.

AddThis Website Tools
admin

Recent Posts

Givaudan tops 2024 forecasts with robust gross sales progress throughout markets

(Reuters) -Swiss perfume and flavour maker Givaudan on Friday reported annual outcomes above market expectations,…

8 minutes ago

German enterprise exercise stabilises in January, PMI reveals

By Maria Martinez BERLIN (Reuters) - Enterprise exercise in Germany's non-public sector stabilised in January,…

13 minutes ago

Cosmos well being CEO Grigorios Siokas acquires shares price $29,999

The acquisition is a part of a debt alternate settlement between Mr. Siokas and Cosmos…

23 minutes ago

Inhibrx’s SWOT evaluation: oncology biotech inventory faces pivotal 12 months forward

Inhibrx Biosciences , Inc. (NASDAQ:INBX), a clinical-stage biopharmaceutical firm valued at $205.41 million, is navigating…

38 minutes ago

Japanese pay hikes should exceed final yr’s, Rengo union head says

By Anton Bridge and Tetsushi Kajimoto TOKYO (Reuters) -Japanese annual pay will increase this yr…

43 minutes ago

Monte dei Paschi launches 13.3-billion-euro all share bid for Mediobanca

(Reuters) - Bailed-out lender Monte dei Paschi di Siena (MPS) stated on Friday it was…

58 minutes ago